{"created":"2025-02-21T03:40:56.289181+00:00","id":2007088,"links":{},"metadata":{"_buckets":{"deposit":"f8303bf1-0cce-46a9-a75d-88511ec2eafd"},"_deposit":{"created_by":41,"id":"2007088","owners":[41],"pid":{"revision_id":0,"type":"depid","value":"2007088"},"status":"published"},"_oai":{"id":"oai:hiroshima.repo.nii.ac.jp:02007088","sets":["1730444907710"]},"author_link":[],"item_1617186331708":{"attribute_name":"Title","attribute_value_mlt":[{"subitem_title":"Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer","subitem_title_language":"en"}]},"item_1617186419668":{"attribute_name":"Creator","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Matsuura, Kanji","creatorNameLang":"en"}],"familyNames":[{"familyName":"Matsuura","familyNameLang":"en"}],"givenNames":[{"givenName":"Kanji","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kimura, Tomoki","creatorNameLang":"en"}],"familyNames":[{"familyName":"Kimura","familyNameLang":"en"}],"givenNames":[{"givenName":"Tomoki","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kashiwado, Kozo","creatorNameLang":"en"}],"familyNames":[{"familyName":"Kashiwado","familyNameLang":"en"}],"givenNames":[{"givenName":"Kozo","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Fujita, Kazushi","creatorNameLang":"en"}],"familyNames":[{"familyName":"Fujita","familyNameLang":"en"}],"givenNames":[{"givenName":"Kazushi","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Akagi, Yukio","creatorNameLang":"en"}],"familyNames":[{"familyName":"Akagi","familyNameLang":"en"}],"givenNames":[{"givenName":"Yukio","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Yuki, Shintarou","creatorNameLang":"en"}],"familyNames":[{"familyName":"Yuki","familyNameLang":"en"}],"givenNames":[{"givenName":"Shintarou","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Murakami, Yuji","creatorNameLang":"en"}],"familyNames":[{"familyName":"Murakami","familyNameLang":"en"}],"givenNames":[{"givenName":"Yuji","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Wadasaki, Koichi","creatorNameLang":"en"}],"familyNames":[{"familyName":"Wadasaki","familyNameLang":"en"}],"givenNames":[{"givenName":"Koichi","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Monzen, Yoshio","creatorNameLang":"en"}],"familyNames":[{"familyName":"Monzen","familyNameLang":"en"}],"givenNames":[{"givenName":"Yoshio","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ito, Atsushi","creatorNameLang":"en"}],"familyNames":[{"familyName":"Ito","familyNameLang":"en"}],"givenNames":[{"givenName":"Atsushi","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Kagemoto, Masayuki","creatorNameLang":"en"}],"familyNames":[{"familyName":"Kagemoto","familyNameLang":"en"}],"givenNames":[{"givenName":"Masayuki","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Mori, Masaki","creatorNameLang":"en"}],"familyNames":[{"familyName":"Mori","familyNameLang":"en"}],"givenNames":[{"givenName":"Masaki","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Ito, Katsuhide","creatorNameLang":"en"}],"familyNames":[{"familyName":"Ito","familyNameLang":"en"}],"givenNames":[{"givenName":"Katsuhide","givenNameLang":"en"}]},{"creatorNames":[{"creatorName":"Nagata, Yasushi","creatorNameLang":"en"}],"familyNames":[{"familyName":"Nagata","familyNameLang":"en"}],"givenNames":[{"givenName":"Yasushi","givenNameLang":"en"}]}]},"item_1617186476635":{"attribute_name":"Access Rights","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_1617186499011":{"attribute_name":"Rights","attribute_value_mlt":[{"subitem_rights":"Copyright (c) 2009 Springer"}]},"item_1617186609386":{"attribute_name":"Subject","attribute_value_mlt":[{"subitem_subject":"Involved-field radiation therapy (IFRT)","subitem_subject_scheme":"Other"},{"subitem_subject":"Elective nodal irradiation (ENI)","subitem_subject_scheme":"Other"},{"subitem_subject":"Three-dimensional conformal radiation therapy (3DCRT)","subitem_subject_scheme":"Other"},{"subitem_subject":"Non-small-cell lung cancer (NSCLC)","subitem_subject_scheme":"Other"},{"subitem_subject":"Carboplatin (CBDCA)","subitem_subject_scheme":"Other"},{"subitem_subject":"Paclitaxel (PTX)","subitem_subject_scheme":"Other"},{"subitem_subject":"490","subitem_subject_scheme":"NDC"}]},"item_1617186626617":{"attribute_name":"Description","attribute_value_mlt":[{"subitem_description":"We aimed to evaluate the feasibility and efficacy of hypofractionated involved-field radiation therapy (IFRT) omitting elective nodal irradiation (ENI) with concurrent chemotherapy for locally advanced non-small-cell lung cancer (NSCLC). Between July 2004 and July 2006, ten patients with locally advanced NSCLC were included in this study. One had stage IIIA and 9 had stage IIIB disease. The treatment consisted of IFRT in fractions of 2.5 Gy and weekly carboplatin (CBDCA)/paclitaxel (PTX). Hypofractionated IFRT with a median total dose of 65 Gy with median percent total lung volume exceeding 20 Gy (V20) of 20.2%, and a median of five courses of chemotherapy with weekly CBDCA (area under the curve, 1.5-2.0)/PTX (30-35 mg/m(2)) were given to all patients. The median survival time and the 1-, 2-, and 3-year overall survival rates were 29.5 months and 90.0%, 58.3%, and 43.8%, respectively. No elective nodal failure was encountered during the median follow up of 18.2 months. No acute or late toxicities of grade 3 or worse were observed. No in-field recurrence occurred in the group with a total dose of 67.5 Gy or more, but there was such recurrence in 83.3% of those in the group with less than 67.5 Gy. Hypofractionated IFRT with weekly CBDCA/PTX was a feasible treatment regimen. Hypofractionated IFRT with a total dose of 67.5 Gy or more could be a promising modality to improve the treatment results in patients with locally advanced NSCLC.","subitem_description_language":"en"}]},"item_1617186643794":{"attribute_name":"Publisher","attribute_value_mlt":[{"subitem_publisher":"Springer Tokyo"}]},"item_1617186702042":{"attribute_name":"Language","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_1617186920753":{"attribute_name":"Source Identifier","attribute_value_mlt":[{"subitem_source_identifier":"1341-9625","subitem_source_identifier_type":"ISSN"},{"subitem_source_identifier":"AA11086579","subitem_source_identifier_type":"NCID"}]},"item_1617187024783":{"attribute_name":"Page Start","attribute_value_mlt":[{"subitem_start_page":"408"}]},"item_1617187056579":{"attribute_name":"Bibliographic Information","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2009-10-24","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"5","bibliographicPageEnd":"415","bibliographicPageStart":"408","bibliographicVolumeNumber":"14","bibliographic_titles":[{"bibliographic_title":"International Journal of Clinical Oncology"},{"bibliographic_title":"International Journal of Clinical Oncology"}]}]},"item_1617258105262":{"attribute_name":"Resource Type","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_1617265215918":{"attribute_name":"Version Type","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_b1a7d7d4d402bcce","subitem_version_type":"AO"}]},"item_1617353299429":{"attribute_name":"Relation","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"The original publication is available at www.springerlink.com"}]},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1007/s10147-009-0889-0","subitem_relation_type_select":"DOI"}},{"subitem_relation_type_id":{"subitem_relation_type_id_text":"http://dx.doi.org/10.1007/s10147-009-0889-0","subitem_relation_type_select":"DOI"}}]},"item_1617605131499":{"attribute_name":"File","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_access","date":[{"dateType":"Available","dateValue":"2023-03-18"}],"displaytype":"simple","filename":"Int-J-Clin-Oncol_14_408.pdf","filesize":[{"value":"361.3 KB"}],"mimetype":"application/pdf","url":{"objectType":"fulltext","url":"https://hiroshima.repo.nii.ac.jp/record/2007088/files/Int-J-Clin-Oncol_14_408.pdf"},"version_id":"d8a6455b-127d-4a8e-bcfa-7393c538102d"}]},"item_1732771732025":{"attribute_name":"旧ID","attribute_value":"28880"},"item_title":"Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer","item_type_id":"40003","owner":"41","path":["1730444907710"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-03-18"},"publish_date":"2023-03-18","publish_status":"0","recid":"2007088","relation_version_is_last":true,"title":["Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer"],"weko_creator_id":"41","weko_shared_id":-1},"updated":"2025-02-21T09:06:05.563263+00:00"}